Desmoid Tumor clinical trials at UCSF

• Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

  open to eligible people ages 18 years and up

  This study evaluates nirogacestat in the treatment of desmoid tumor/aggressive fibromatosis (DT/AF). Half of the participants will receive nirogacestat while the other half will receive placebo.

  San Francisco, California and other locations

Last updated: April 20, 2020